Efficacy and Safety of Low-Dose Cyclosporine with Everolimus and Steroids in de novo Heart Transplant Patients: A Multicentre, Randomized Trial
Figure 2
CsA C2 level during the six-month study. Shaded areas indicate target C2 ranges (hatched area, shared target to Day 59; dark area, reduced-CsA; light area, standard-CsA). Values are shown as mean±SD (central laboratory results).
